LSE - Delayed Quote GBp
MaxCyte, Inc. (MXCT.L)
212.20
-2.80
(-1.30%)
As of 11:07:11 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-27,610
-27,610
-21,686
-14,783
-10,679.60
Investing Cash Flow
6,932
6,932
54,984
-24,823
-195,013.20
Financing Cash Flow
2,056
2,056
2,143
2,888
234,720
End Cash Position
27,884
27,884
46,506
11,065
47,782.40
Interest Paid Supplemental Data
--
--
--
--
420.90
Capital Expenditure
-1,651
-1,651
-3,700
-18,477
-3,834.20
Issuance of Capital Stock
--
--
269
--
236,077.30
Repayment of Debt
--
--
--
--
-4,988.50
Free Cash Flow
-29,261
-29,261
-25,386
-33,260
-14,513.80
12/31/2021 - 3/29/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EKF.L EKF Diagnostics Holdings plc
21.40
+4.39%
CTKB Cytek Biosciences, Inc.
3.8400
-0.52%
OWLT Owlet, Inc.
4.0900
+3.96%
SN.L Smith & Nephew plc
988.00
-1.00%
UFPT UFP Technologies, Inc.
211.25
+0.69%
CODX Co-Diagnostics, Inc.
0.3701
-0.27%
BRKR Bruker Corporation
39.56
-0.25%
BIO Bio-Rad Laboratories, Inc.
237.92
-0.94%
RBOT Vicarious Surgical Inc.
8.46
-0.12%
QSI Quantum-Si incorporated
1.2101
+0.01%